14-64793509-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.2154A>C​(p.Ile718Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 1,613,834 control chromosomes in the GnomAD database, including 121,799 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 16184 hom., cov: 32)
Exomes 𝑓: 0.37 ( 105615 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.30

Publications

14 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 14-64793509-T-G is Benign according to our data. Variant chr14-64793509-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.3 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001355436.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTB
NM_001355436.2
MANE Select
c.2154A>Cp.Ile718Ile
synonymous
Exon 14 of 36NP_001342365.1
SPTB
NM_001024858.4
c.2154A>Cp.Ile718Ile
synonymous
Exon 13 of 35NP_001020029.1
SPTB
NM_001355437.2
c.2154A>Cp.Ile718Ile
synonymous
Exon 14 of 32NP_001342366.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTB
ENST00000644917.1
MANE Select
c.2154A>Cp.Ile718Ile
synonymous
Exon 14 of 36ENSP00000495909.1
SPTB
ENST00000389722.7
TSL:2
c.2154A>Cp.Ile718Ile
synonymous
Exon 13 of 35ENSP00000374372.3
SPTB
ENST00000389720.4
TSL:5
c.2154A>Cp.Ile718Ile
synonymous
Exon 14 of 32ENSP00000374370.4

Frequencies

GnomAD3 genomes
AF:
0.440
AC:
66863
AN:
151936
Hom.:
16156
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.650
Gnomad AMI
AF:
0.481
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.431
Gnomad EAS
AF:
0.195
Gnomad SAS
AF:
0.505
Gnomad FIN
AF:
0.345
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.364
Gnomad OTH
AF:
0.420
GnomAD2 exomes
AF:
0.378
AC:
94946
AN:
250852
AF XY:
0.384
show subpopulations
Gnomad AFR exome
AF:
0.654
Gnomad AMR exome
AF:
0.273
Gnomad ASJ exome
AF:
0.434
Gnomad EAS exome
AF:
0.183
Gnomad FIN exome
AF:
0.336
Gnomad NFE exome
AF:
0.372
Gnomad OTH exome
AF:
0.380
GnomAD4 exome
AF:
0.373
AC:
545365
AN:
1461780
Hom.:
105615
Cov.:
84
AF XY:
0.378
AC XY:
274552
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.664
AC:
22240
AN:
33480
American (AMR)
AF:
0.285
AC:
12757
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.445
AC:
11635
AN:
26136
East Asian (EAS)
AF:
0.209
AC:
8290
AN:
39700
South Asian (SAS)
AF:
0.500
AC:
43163
AN:
86256
European-Finnish (FIN)
AF:
0.337
AC:
17966
AN:
53330
Middle Eastern (MID)
AF:
0.435
AC:
2511
AN:
5768
European-Non Finnish (NFE)
AF:
0.362
AC:
403033
AN:
1111996
Other (OTH)
AF:
0.394
AC:
23770
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
25563
51126
76689
102252
127815
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12792
25584
38376
51168
63960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.440
AC:
66939
AN:
152054
Hom.:
16184
Cov.:
32
AF XY:
0.438
AC XY:
32540
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.650
AC:
26948
AN:
41472
American (AMR)
AF:
0.343
AC:
5237
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.431
AC:
1495
AN:
3468
East Asian (EAS)
AF:
0.195
AC:
1008
AN:
5166
South Asian (SAS)
AF:
0.504
AC:
2426
AN:
4818
European-Finnish (FIN)
AF:
0.345
AC:
3651
AN:
10570
Middle Eastern (MID)
AF:
0.439
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
0.364
AC:
24722
AN:
67958
Other (OTH)
AF:
0.420
AC:
886
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1851
3702
5554
7405
9256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
27158
Bravo
AF:
0.446
Asia WGS
AF:
0.407
AC:
1415
AN:
3478
EpiCase
AF:
0.379
EpiControl
AF:
0.385

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary spherocytosis type 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.2
DANN
Benign
0.70
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs229591; hg19: chr14-65260227; COSMIC: COSV67633734; API